Research Article

A Metabolomic Investigation of Eugenol on Colorectal Cancer Cell Line HT-29 by Modifying the Expression of APC, p53, and KRAS Genes

Table 2

Inhibitory effects of the HT-29 cell line treated with eugenol for 24, 48, and 72 hours. This experiment was performed in three replications. Data are presented as mean ± SD of three independent experiments.

Cell survival percentage% ± SD
Eugenol concentration (μM)24 hours48 hours72 hours

097/29 ± 1/6897/04 ± 1/4396/29 ± 1/01
10097/34 ± 2/8693/83 ± 2/6686/51 ± 2/58
20095/28 ± 3/1880/61 ± 1/53373/81 ± 1/19
30088/06 ± 2/7373/59 ± 1/4865/91 ± 2/63
40078/02 ± 1/7161/18 ± 3/3553/14 ± 3/15
50066/81 ± 3/2847/39 ± 3/6842/80 ± 2/41
60052/04 ± 2/3736/28 ± 1/1629/51 ± 1/32
70041/46 ± 1/0923/43 ± 2/7117/43 ± 3/23
IC50584/72 ± 5/27523/64 ± 3/23451/69 ± 5/09

().